Brian Baranick Exact Sciences Corp (EXAS) insider trading activity

Brian Baranick is EVP, GM, Precision Oncology of EXACT SCIENCES CORP. Currently has a direct ownership of 12,758 shares of EXAS, which is worth approximately $741,367. The most recent transaction as insider was on Oct 08, 2024, when has been sold 929 shares (Common Stock) at a price of $70.0 per share, resulting in proceeds of $65,030. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K

6.79% 3M change

43.82% 12M change

Total Value Held $741,367

Brian Baranick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 08 2024	SELL Open market or private sale	$65,030 $70.0 p/Share	929 Reduced 6.79%	12,758 Common Stock
Sep 18 2024	SELL Open market or private sale	$65,030 $70.0 p/Share	929 Reduced 6.36%	13,687 Common Stock
Aug 05 2024	SELL Payment of exercise price or tax liability	$76,683 $55.77 p/Share	1,375 Reduced 8.6%	14,616 Common Stock
Aug 05 2024	BUY Exercise of conversion of derivative security	-	2,712 Added 14.5%	15,991 Common Stock
May 01 2024	SELL Open market or private sale	$6,616 $60.15 p/Share	110 Reduced 0.82%	13,279 Common Stock
Apr 30 2024	BUY Grant, award, or other acquisition	-	218 Added 1.6%	13,389 Common Stock
Apr 02 2024	SELL Open market or private sale	$73,393 $79.43 p/Share	924 Reduced 6.56%	13,171 Common Stock
Mar 01 2024	SELL Open market or private sale	$137,800 $59.32 p/Share	2,323 Reduced 14.15%	14,095 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	-	4,724 Added 22.34%	16,418 Common Stock
Feb 27 2024	SELL Open market or private sale	$115,316 $56.89 p/Share	2,027 Reduced 14.77%	11,694 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	3,954 Added 22.37%	13,721 Common Stock
Feb 22 2024	SELL Open market or private sale	$65,339 $59.78 p/Share	1,093 Reduced 10.06%	9,767 Common Stock
Feb 21 2024	SELL Open market or private sale	$55,042 $61.5 p/Share	895 Reduced 9.21%	8,826 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	2,034 Added 15.77%	10,860 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	1,729 Added 15.1%	9,721 Common Stock
Jan 02 2024	SELL Open market or private sale	$64,606 $73.5 p/Share	879 Reduced 9.91%	7,992 Common Stock
Aug 07 2023	SELL Open market or private sale	$114,804 $85.04 p/Share	1,350 Reduced 13.21%	8,871 Common Stock
Aug 04 2023	BUY Exercise of conversion of derivative security	-	2,712 Added 20.97%	10,221 Common Stock
Feb 28 2023	SELL Open market or private sale	$118,083 $61.12 p/Share	1,932 Reduced 20.46%	7,509 Common Stock
Feb 27 2023	BUY Exercise of conversion of derivative security	-	3,954 Added 29.52%	9,441 Common Stock
Feb 22 2023	SELL Open market or private sale	$52,559 $62.72 p/Share	838 Reduced 13.25%	5,487 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	1,729 Added 21.47%	6,325 Common Stock
Aug 05 2022	SELL Open market or private sale	$46,366 $47.12 p/Share	984 Reduced 17.63%	4,596 Common Stock
Aug 04 2022	BUY Exercise of conversion of derivative security	-	2,712 Added 32.71%	5,580 Common Stock

Brian Baranick

EVP, GM, Precision Oncology

Madison, WI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Value

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS

Account